Compare Abeona Therapeutics Inc (ABEO) vs American Tower Corp (AMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs American Tower Corp — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while American Tower Corp trades at $169.49 (market cap $79.00B). The key difference: American Tower Corp is far larger — about 187.6× Abeona Therapeutics Inc's market cap, and American Tower Corp pays a 4.12% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | AMT | |
|---|---|---|
Market Cap | $421.19M | $79.00B |
Sector | Health | Real Estate |
52-Week High | $7.45 | $211.88 |
52-Week Low | $4.17 | $162.11 |
Enterprise Value | $276.10M | $122.53B |
Dividend Yield | — | 4.12% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About American Tower Corp
American Tower owns and operates more than 220,000 cell towers throughout the U.S., Asia, Latin America, Europe, and Africa. It also owns and/or operates 25 data centers in eight U.S. markets after acquiring CoreSite. On its towers, the company has a very concentrated customer base, with most revenue in each market being generated by just the top few mobile carriers. The company operates more than 40,000 towers in the U.S., which accounted for more than half of its total revenue in 2021. Outside the U.S., American Tower's greatest presence is in India and Brazil, where it operates roughly 75,000 and 19,000 towers, respectively. American Tower operates as a real estate investment trust.
Read more on AMT →
